{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:20:04Z","timestamp":1780521604562,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.7759\/cureus.99037","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:25:21Z","timestamp":1765542321000},"source":"Crossref","is-referenced-by-count":1,"title":["Integrating Classical Tumor Markers and Systemic Inflammatory Indices for Enhanced Biological Profiling in Testicular Neoplasms"],"prefix":"10.7759","author":[{"given":"Sadik","family":"Portakal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basri","family":"Cakiroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Solak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1833","article-title":"Metachronous testicular cancer after orchiectomy: a rare case","volume":"9","author":"Arda E","year":"2017","unstructured":"Arda E, Cakiroglu B, Cetin G, Yuksel I. Metachronous testicular cancer after orchiectomy: a rare case. Cureus. 2017, 9:e1833. 10.7759\/cureus.1833","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5336\/urology.2020-78508","article-title":"Evaluation of the reliability, utility, and quality of the information in testicular cancer self-exam videos shared on YouTube","volume":"2020","author":"Ta\u015f T","unstructured":"Ta\u015f T, Arda E, \u00c7ak\u0131ro\u011flu B, U\u00e7ar T. Evaluation of the reliability, utility, and quality of the information in testicular cancer self-exam videos shared on YouTube. J Reconstr Urol. 2020:80-7. 10.5336\/urology.2020-78508","journal-title":"J Reconstr Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/his.13102","article-title":"The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel","volume":"70","author":"Williamson SR","year":"2017","unstructured":"Williamson SR, Delahunt B, Magi-Galluzzi C, et al.. The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology. 2017, 70:335-46. 10.1111\/his.13102","journal-title":"Histopathology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5030349","article-title":"Serum tumour markers in testicular germ cell tumours: frequencies of elevated levels and extents of marker elevation are significantly associated with clinical parameters and with response to treatment","volume":"2019","author":"Dieckmann KP","year":"2019","unstructured":"Dieckmann KP, Simonsen-Richter H, Kulejewski M, et al.. Serum tumour markers in testicular germ cell tumours: frequencies of elevated levels and extents of marker elevation are significantly associated with clinical parameters and with response to treatment. Biomed Res Int. 2019, 2019:5030349. 10.1155\/2019\/5030349","journal-title":"Biomed Res Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-023-01302-y","article-title":"Tumor necrosis factor-\u03b1 induces proliferation and reduces apoptosis of colorectal cancer cells through STAT3 activation","volume":"75","author":"Wei W","year":"2023","unstructured":"Wei W, Wang J, Huang P, et al.. Tumor necrosis factor-\u03b1 induces proliferation and reduces apoptosis of colorectal cancer cells through STAT3 activation. Immunogenetics. 2023, 75:161-9. 10.1007\/s00251-023-01302-y","journal-title":"Immunogenetics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.01.001","article-title":"The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: A diagnostic test accuracy systematic review","volume":"59","author":"Nicholson BD","year":"2019","unstructured":"Nicholson BD, Jones NR, Protheroe A, et al.. The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: A diagnostic test accuracy systematic review. Cancer Epidemiol. 2019, 59:15-21. 10.1016\/j.canep.2019.01.001","journal-title":"Cancer Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32520","article-title":"Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis","volume":"146","author":"Carella A","year":"2020","unstructured":"Carella A, Tejedor JR, Garc\u00eda MG, et al.. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis. Int J Cancer. 2020, 146:373-87. 10.1002\/ijc.32520","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.01.002","article-title":"Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oldenburg J","year":"2022","unstructured":"Oldenburg J, Berney DM, Bokemeyer C, et al.. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022, 33:362-75. 10.1016\/j.annonc.2022.01.002","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12019","article-title":"Congenital bilateral absence of the vas deferens: the impact of spermatogenesis quality on intracytoplasmic sperm injection outcomes in 108 men","volume":"3","author":"Llabador MA","year":"2015","unstructured":"Llabador MA, Pagin A, Lefebvre-Maunoury C, et al.. Congenital bilateral absence of the vas deferens: the impact of spermatogenesis quality on intracytoplasmic sperm injection outcomes in 108 men. Andrology. 2015, 3:473-80. 10.1111\/andr.12019","journal-title":"Andrology"},{"key":"ref10","article-title":"Testicular cancer: discoveries and updates","volume":"27","author":"Hanna NH","year":"2014","unstructured":"Hanna NH, Einhorn LH. Testicular cancer: discoveries and updates. N Engl J Med. 2014, 27:1230-1241.","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2011.01157.x","article-title":"Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance","volume":"34","author":"Looijenga LH","year":"2011","unstructured":"Looijenga LH, Gillis AJ, Stoop H, et al.. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl. 2011, 34:e234-51. 10.1111\/j.1365-2605.2011.01157.x","journal-title":"Int J Androl"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker F","year":"2018","unstructured":"Honecker F, Aparicio J, Berney D, et al.. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018, 29:1658-86. 10.1093\/annonc\/mdy217","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000525","article-title":"Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours","volume":"28","author":"Pedraza AM","year":"2018","unstructured":"Pedraza AM, Stephenson AJ. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours. Curr Opin Urol. 2018, 28:448-53. 10.1097\/MOU.0000000000000525","journal-title":"Curr Opin Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1148\/rg.282075048","article-title":"Fournier gangrene: role of imaging","volume":"28","author":"Levenson RB","year":"2008","unstructured":"Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008, 28:519-28. 10.1148\/rg.282075048","journal-title":"Radiographics"},{"key":"ref15","article-title":"Testicular germ cell tumors","volume":"28","author":"Horwich A","year":"2013","unstructured":"Horwich A, Parker C, Nicol D, et al.. Testicular germ cell tumors. BMJ. 2013, 28:327.","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01859.x","article-title":"Bilateral testicular intratubular germ-cell neoplasia, unclassified in an azoospermic patient","volume":"14","author":"Vassilis A","year":"2007","unstructured":"Vassilis A, Vassilis P, Eleni P, et al.. Bilateral testicular intratubular germ-cell neoplasia, unclassified in an azoospermic patient. Int J Urol. 2007, 14:1051-3. 10.1111\/j.1442-2042.2007.01859.x","journal-title":"Int J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437345-integrating-classical-tumor-markers-and-systemic-inflammatory-indices-for-enhanced-biological-profiling-in-testicular-neoplasms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:25:22Z","timestamp":1765542322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437345-integrating-classical-tumor-markers-and-systemic-inflammatory-indices-for-enhanced-biological-profiling-in-testicular-neoplasms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.99037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}